34 related articles for article (PubMed ID: 25771901)
1. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
[TBL] [Abstract][Full Text] [Related]
2. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells.
Kobayashi D; Koshida S; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):334-40. PubMed ID: 17270022
[TBL] [Abstract][Full Text] [Related]
3. Paneth-like cells produced from OLFM4
Sakahara M; Okamoto T; Srivastava U; Natsume Y; Yamanaka H; Suzuki Y; Obama K; Nagayama S; Yao R
Commun Biol; 2024 Jan; 7(1):27. PubMed ID: 38182890
[TBL] [Abstract][Full Text] [Related]
4. The Olfactomedin-4-Defined Human Neutrophil Subsets Differ in Proteomic Profile in Healthy Individuals and Patients with Septic Shock.
Lundquist H; Andersson H; Chew MS; Das J; Turkina MV; Welin A
J Innate Immun; 2023; 15(1):351-364. PubMed ID: 36450268
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS.
Kangelaris KN; Prakash A; Liu KD; Aouizerat B; Woodruff PG; Erle DJ; Rogers A; Seeley EJ; Chu J; Liu T; Osterberg-Deiss T; Zhuo H; Matthay MA; Calfee CS
Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(11):L1102-13. PubMed ID: 25795726
[TBL] [Abstract][Full Text] [Related]
6. Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC.
Wei Y; Song Q; Zhang F; Yuan T
Can J Gastroenterol Hepatol; 2021; 2021():5601678. PubMed ID: 34912753
[TBL] [Abstract][Full Text] [Related]
7. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
[TBL] [Abstract][Full Text] [Related]
8. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
[TBL] [Abstract][Full Text] [Related]
9. Olfactomedin-4 in digestive diseases: A mini-review.
Wang XY; Chen SH; Zhang YN; Xu CF
World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
[TBL] [Abstract][Full Text] [Related]
10. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
Liu W; Rodgers GP
Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
[TBL] [Abstract][Full Text] [Related]
11. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
[TBL] [Abstract][Full Text] [Related]
12. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
15. [Expression of granulocyte colony stimulating factor in patients with non-small cell lung cancer and its clinicopathological significance].
Wei LX; Chang WL; Guo AT; Tai YH; Sun L; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):721-5. PubMed ID: 22336152
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
